HC
APLS

Henshaw Capital’s Apellis Pharmaceuticals APLS Stock Holding History

Henshaw Capital’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,595
Closed -$215K – 285
2023
Q4 		$215K Sell
3,595
-3,240
-47% -$164K 0.01% 272
2023
Q3 		$260K Buy
6,835
+3,460
+103% +$152K 0.02% 245
2023
Q2 		$307K Sell
3,375
-3,517
-51% -$303K 0.02% 179
2023
Q1 		$455K Hold
6,892
– – 0.03% 135
2022
Q4 		$356K Hold
6,892
– – 0.02% 152
2022
Q3 		$471K Hold
6,892
– – 0.03% 148
2022
Q2 		$312K Buy
6,892
+1,123
+19% +$51.2K 0.02% 210
2022
Q1 		$293K Sell
5,769
-750
-12% -$33.1K 0.02% 252
2021
Q4 		$308K Buy
+6,519
New +$257K 0.02% 260

Other funds holding APLS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return